20-007 - Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
Status: openA Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Treatment for Parkinson's Disease
Description
Parkinson's Disease clinical trial testing a new compound of carbidopa/levodopa that is delivered by a 24 continuous infusion. Previous studies with this new drug have been promising and the purpose of this study is to assess the efficacy, safety, and the tolerability of the drug. Study activities include neurological and physical exams, questionnaire, physical function tests, blood tests.
Sponsors
This trial is sponsored by AbbVie.Interested in Clinical Trial?
Contact the Clinical Trial Coordinator
If you have questions get in touch with this Clinical Trial’s Coordinator by phone at +1 (251) 665-8375 or by email at dlwilliams@health.southalabama.edu.
